Cardinal Health stock heads into the open after a modest gain
Published on 09/15/2026 at 07:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Cardinal Health stock closed at USD 233.53 on the NYSE on September 14, 2026, marking a gain of 0.23% for the session per NYSE data from MarketBeat.
That move kept the shares within a 52-week range between USD 145.87 and USD 258.30, while the broader S&P 500 fell 0.5% to 7,619.98 on September 14, 2026, underscoring the stock's relative resilience against the wider market.
September 14, 2026 in numbers
Cardinal Health Inc. (ISIN US14149Y1082, NYSE: CAH) traded between an intraday low of USD 232.60 and a high of USD 237.57 on the NYSE on September 14, 2026, before settling at USD 233.53, with roughly 820,386 shares changing hands per NYSE data reported by MarketBeat.
The closing price left the stock about 9.6% below its 52-week high of USD 258.30 and well above its 52-week low of USD 145.87, while year-to-date performance improved from USD 205.62 at the start of 2026 to the current USD 233.53 level, a gain of 13.6% per MarketBeat figures.
On the same day, the S&P 500 slipped 0.5% to 7,619.98, signaling a weaker broader tone as Cardinal Health edged higher, and the Nasdaq Composite added 1.0% to 26,333.04, showing that the stock's modest advance occurred in a mixed index backdrop according to market coverage by Zacks and Barchart.
Guidance and conference focus today
At the Morgan Stanley 24th Annual Global Healthcare Conference on September 14, 2026, Cardinal Health outlined guidance targeting 13% to 15% earnings per share growth for fiscal 2027, highlighting contributions from specialty, pharmaceutical and at-home solutions businesses, as summarized by TradingView.
MarketBeat's event calendar shows Cardinal Health participating in the Morgan Stanley conference on September 14, 2026 and another healthcare conference on September 15, 2026, meaning investors today are weighing the implications of the updated medium-term earnings outlook and ongoing conference commentary for the stock's trajectory ahead of the next estimated earnings release on October 29, 2026, as indicated by MarketBeat.
